Found 58 matching trials
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis EARLY_PHASE1 Microdevices have been used to ascertain in vivo drug response, which can l...
Show More Learn More & Join Trial
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer PHASE2 This is a randomized, blinded, non-comparative, two-arm Phase 2 clinical tr...
Show More Location
University of Alabama at Birmingham School of Medicine
Learn More & Join Trial
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval N/A This is an expanded access program (EAP) designed to provide access to Bote...
Show More Location
Multiple Locations
Learn More & Join Trial
ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study PHASE1 The ITHACA study is a phase I study evaluating the safety and toxicity of a...
Show More Learn More & Join Trial
Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers PHASE1 This Phase Ib/IIa study comprises a Main Study and a Study Extension.
The ...
Show More Status
Active Not Recruiting
Location
Istituto Nazionale dei Tumori
Learn More & Join Trial
A Study of AGEN2034 in Advanced Tumors and Cervical Cancer PHASE1 This is a 2-part trial: a Phase 1, open-label, dose-escalation study in par...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer PHASE1 Phase 1b study evaluating the efficacy and immune response to a synthetic l...
Show More Location
Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer PHASE2 Researchers want to discover if the new drug "TG01" will work with particip...
Show More Status
Active Not Recruiting
Location
University of Kansas Cancer Center - Clinical Research Center
Learn More & Join Trial
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer PHASE2 Participants will receive study treatment with agenT-797, botensilimab, bal...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT PHASE1 This study is for people who have high-risk Ewing sarcoma (ES), or a relate...
Show More Location
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Learn More & Join Trial